Three out of four Colorado voters back a bill working its way through the General Assembly that seeks to lower prescription drug costs with a board that could set price limits on expensive medications, according to a new poll from Keating Research released Monday.
The poll â commissioned by Colorado Consumer Health Initiative, Good Business Colorado, the National MS Society and Centennial State Prosperity and conducted between April 20 and 26 â shows broad support for the concept of Senate Bill 21-175 across party, region and age.
That bill would create the Prescription Drug Affordability Board, a five-member panel appointed by Gov. Jared Polis that would research, review and establish payment limits for drugs deemed unaffordable. The governor has previously spoken in support of the measure.
Colorado legislators introduce bill to create Prescription Drug Affordability Board bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
(KWNO)- Winona Area Catholic Schools received a $5,000 grant from the Pharmaceutical Research and Manufacturers of America (PhRMA) Tuesday.
A PhRMA spokesperson said the money will go to helping WACS expand STEM programs to help students learn science, engineering, technology, and mathematic skills. The grant also funds STEM kits that students can take home.
Sen. Jeremy Miller, who joined 3rd and 4th graders for a virtual presentation Tuesday said “STEM education is an essential tool to inspire students to pursue careers in science, technology, engineering, and mathematics,” said Miller. “Today’s learners will be tomorrow’s cancer or vaccine researchers, and these efforts to harness those ambitions is critically important.”
SACRAMENTO, Calif. (CN) The pharmaceutical industry’s effort to block California’s requirement that drug companies publicly notify and explain major price increases has stalled, with a federal judge ruling the landmark transparency law does not violate the First Amendment.
Siding with the state, U.S. District Judge Morrison England Jr. squashed an industry group’s arguments that the 2017 bill infringes drugmakers’ free speech and regulates interstate commerce. Noting the Pharmaceutical Research and Manufacturers of America (PhRMA) willingly bypassed discovery and pushed for summary judgment, England found the group’s case plainly underdeveloped and unfit for market.
“There are genuine disputes of material fact as to whether providing advance notice of certain increases in a prescription drug’s wholesale acquisition cost results in either direct or extraterritorial regulation,” the judge explained while denying the group’s facial challenge. “Ultimately, PhRMA h